Mark Fridlyand - Director, Strategy & Corporate Development

Por um escritor misterioso

Descrição

Mark Fridlyand - Director, Strategy & Corporate Development
Frontiers Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor
Mark Fridlyand - Director, Strategy & Corporate Development
Recombinant Human Thrombopoietin Protein 288-TP-005: R&D Systems
Mark Fridlyand - Director, Strategy & Corporate Development
Alex Fridlyand email address & phone number Newlight Partners Partner contact information - RocketReach
Mark Fridlyand - Director, Strategy & Corporate Development
Mark Fridlyand - Senior Database Developer - Intercontinental Exchange
Mark Fridlyand - Director, Strategy & Corporate Development
ex99-3_004.jpg
Mark Fridlyand - Director, Strategy & Corporate Development
Mark Fridlyand Phone Number, Address, Age, Contact Info, Public Records ᐈ Radaris
Mark Fridlyand - Director, Strategy & Corporate Development
Paving the road to personalized medicine: recommendations on regulatory, intellectual property and reimbursement challenges. - Abstract - Europe PMC
Mark Fridlyand - Director, Strategy & Corporate Development
Mark Fridlyand - Director, Strategy & Corporate Finance at Synonym Biotechnologies
Mark Fridlyand - Director, Strategy & Corporate Development
Team:Moscow/Attributions
Mark Fridlyand - Director, Strategy & Corporate Development
Applications of comprehensive cancer progression models in the fight against cancer (Part 6) - Systems Biology of Cancer
Mark Fridlyand - Director, Strategy & Corporate Development
fC6MQX
Mark Fridlyand - Director, Strategy & Corporate Development
Nuclear Odontogenic Ameloblast-Associated Protein (ODAM) Correlates with Melanoma Sentinel Lymph Node Metastasis
de por adulto (o preço varia de acordo com o tamanho do grupo)